These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16905529)

  • 1. In vitro activity of linezolid against clinical isolates of Fusobacterium spp.
    Daeschlein G; Hoehne C; Assadian O; Daxboeck F; Meinl C; Kramer A; Kekulé AS
    J Antimicrob Chemother; 2006 Oct; 58(4):789-93. PubMed ID: 16905529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations.
    Jones RN; Ross JE; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2006 Feb; 57(2):279-87. PubMed ID: 16326811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of linezolid resistance in Germany, 2001-2002.
    Brauers J; Kresken M; Hafner D; Shah PM;
    Clin Microbiol Infect; 2005 Jan; 11(1):39-46. PubMed ID: 15649302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.
    Guna R; Muñoz C; Domínguez V; García-García A; Gálvez J; de Julián-Ortiz JV; Borrás R
    J Antimicrob Chemother; 2005 Jun; 55(6):950-3. PubMed ID: 15824090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents.
    Koeth LM; Good CE; Appelbaum PC; Goldstein EJ; Rodloff AC; Claros M; Dubreuil LJ
    J Antimicrob Chemother; 2004 Jun; 53(6):1039-44. PubMed ID: 15128729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tinidazole inhibitory and cidal activity against anaerobic periodontal pathogens.
    Alou L; Giménez MJ; Manso F; Sevillano D; Torrico M; González N; Granizo JJ; Bascones A; Prieto J; Maestre JR; Aguilar L
    Int J Antimicrob Agents; 2009 May; 33(5):449-52. PubMed ID: 19097755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.
    Jones RN; Fritsche TR; Sader HS; Ross JE
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):199-209. PubMed ID: 17908617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, microbial interactions, and antimicrobial susceptibility of Fusobacterium nucleatum and Fusobacterium necrophorum isolated from primary endodontic infections.
    Jacinto RC; Montagner F; Signoretti FG; Almeida GC; Gomes BP
    J Endod; 2008 Dec; 34(12):1451-6. PubMed ID: 19026872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro time-kill assessment of linezolid and anaerobic bacteria.
    Yagi BH; Zurenko GE
    Anaerobe; 2003 Feb; 9(1):1-3. PubMed ID: 16887680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria.
    Molicotti P; Ortu S; Bua A; Cannas S; Sechi LA; Zanetti S
    New Microbiol; 2006 Oct; 29(4):275-80. PubMed ID: 17201094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline.
    Zinner SH; Gilbert D; Lubenko IY; Greer K; Firsov AA
    J Antimicrob Chemother; 2008 Mar; 61(3):629-35. PubMed ID: 18245198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
    Erturan Z; Uzun M
    Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antibiotic susceptibility of Bacteroides, Prevotella and Fusobacterium species isolated from patients of the N. N. Blokhin Cancer Research Center, Moscow, Russia.
    Shilnikova II; Dmitrieva NV
    Anaerobe; 2015 Feb; 31():15-8. PubMed ID: 25157873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
    Anastasiou DM; Thorne GM; Luperchio SA; Alder JD
    Int J Antimicrob Agents; 2006 Nov; 28(5):385-8. PubMed ID: 17046205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP; Bierman BC
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of bifidobacteria.
    Moubareck C; Gavini F; Vaugien L; Butel MJ; Doucet-Populaire F
    J Antimicrob Chemother; 2005 Jan; 55(1):38-44. PubMed ID: 15574479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
    Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
    Ermertcan S; Hosgor-Limoncu M; Erac B; Tasli H; Cavusoglu C; Bozkurt H
    Jpn J Infect Dis; 2009 Sep; 62(5):384-5. PubMed ID: 19762990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.